Simple math illustrates the challenge facing U.S. taxpayers, consumers and insurers following the launch late last year of two expensive new drugs to treat hepatitis C. If all 3 million people estimated to be infected with the virus in America...
These are exciting times in the treatment of hepatitis C virus infection. The outlook for patients with hepatitis C has greatly improved with available treatment options offering a cure for many. Until 2011, the standard of care for patients with hepatitis C was combination treatment of pegylated interferon and ribavirin. Treatment with peginterferon and ribavirin […]
Who accredits health plans for mental health parity compliance? Learn about the only organization that offers this program to ensure your members get equitable care.
Offering a first glimpse of the health care needs of Americans who bought coverage through federal and state marketplaces, an analysis of the first two months of claims data shows the new enrollees are more likely to use expensive specialty drugs ...